SEC Form 4 · accession 0001193125-26-281304
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Haddock
Officer — EVP, GC & Corp Sec
Period of report
Jun 22, 2026
Accepted (ET)
Jun 24, 2026 · 5:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 22, 2026 | A | 20,036 | $0.00 | A | 20,036 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Performance Share UnitF2 | — | Jun 22, 2026 | A | 51,000 | A | — | — | Common Stock | 51,000 | 51,000 | D |
Explanation of responses
- F1Restricted shares granted pursuant to the Issuer's Second Amended and Restated 2008 Incentive Compensation Plan (the "Plan"), in connection with an annual equity award. Twenty-five percent (25%) of the restricted shares will vest on June 1, 2027, twenty-five percent (25%) of the restricted shares will vest on June 1, 2028 and fifty percent (50%) of the restricted shares will vest on June 1, 2029, subject to the terms of the Plan.
- F2Each Performance Share Unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock upon vesting. The PSUs vest upon the satisfaction of both a service-based condition and a performance-based condition. The PSUs will vest, to the extent earned, on the three-year anniversary of the grant date, with the shares underlying the PSUs being earned in one-third installments based on the Issuer achieving stock price hurdles equal to 115%, 125% and 135% of $22.66 for at least 20 consecutive trading days before the third anniversary of the grant date.